{"id": "1354421430742626306", "creation": 1611754207.0, "user_id": "132897310", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Interim data from the Phase III trial evaluating REGEN-COV\u2122 as a passive #vaccine to prevent #Covid19 finds it reduces overall infection rate and length of infection.\n#antibodies #clinicaltrials #biopharma #biologics\nRead on: https://t.co/LrDTDVsPNF https://t.co/GnFmLe52sT", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#ANTIBODIES", "#CLINICALTRIALS", "#BIOPHARMA", "#BIOLOGICS"]}